ARCHIVES

In Brief: DeVita On Laetrile Hit List; Hammer Removal As Panel Head Sought By Love Canal Activist

This article is from The Cancer Letter archive.

Vol. 07 No. 45 | November 6, 1981

Download PDF Visit The Full Archive

Related Articles

Annual Report Finds Decreases In Overall Cancer Rates

December 11, 2009

Cooperative Groups Won’t Get Grants For Head & Neck Cancer, Must Compete For Contract Awards

July 1, 1977

DCPC To Merge Two Programs, Reorganizes Chemoprevention

November 4, 1994

ODAC Oks Carboplatin As 1st Line Ovarian Therapy; Other Drugs

July 12, 1991

Blacks, Whites Have Same Contralateral Breast Cancer Risk While On Tamoxifen

December 31, 2004

DeVita, Moertel Debate Timing Of Levamisole Update

February 16, 1990